The FDA warns about using GLP-1 drugs like semaglutide for non-medical reasons
Semaglutide for management of obesity in adolescents: efficacy, safety, and considerations for clinical practice
Samsonraj R M, Raghunath M
NICE guidance (TA875) recommends its use within specialist weight management services, with specific NHS commissioning criteria (typically BMI 35 kg/m with comorbidity, with exceptions for BMI 30-34.9) and a maximum treatment duration of 2 years
Personal breathalysers are compact, easy to use, and offer a quick way to check if youre over the legal limit before driving or engaging in other activities
Our highly trained technicians use the latest laser machines that are painless, effective, and safe